Beam Therapeutics Inc. Public Float
Beam Therapeutics Inc. (BEAM) had Public Float of $1.70 billion as of 2025-06-30, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-24
- 2025-06-30: Entity Public Float $1.70B.
- 2024-06-28: Entity Public Float $1.91B.
- 2023-06-30: Entity Public Float $2.11B.
- 2022-06-30: Entity Public Float $2.46B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.70B 10-K · filed 2026-02-24 |
| 2024-06-28 | $1.91B 10-K · filed 2025-02-25 |
| 2023-06-30 | $2.11B 10-K · filed 2024-02-27 |
| 2022-06-30 | $2.46B 10-K · filed 2023-02-28 |
| 2021-06-30 | $6.45B 10-K · filed 2022-02-28 |
| 2020-06-30 | $982.17M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |